Table 1.
Patients’ demographics of safety population
| Placebo (n = 58) | Verum (n = 58) | p value | |
|---|---|---|---|
| Sex female, n (%) | 29 (50) | 26 (45) | 0.71 |
| Height, cm | 173.5 (8.7), 152–197 | 173.5 (8.6), 158–198 | 0.78 |
| Weight, kg | 78.0 (14.6) 52–110 | 75.9 (14.3), 52–107 | 0.46 |
| BMI | 25.8 (4.1), 18.6–37.0 | 25.2 (4.4), 17.8–39.1 | 0.38 |
| Age, years | 39.3 (13.6), 19–76 | 35.7 (15.8), 18–84 | 0.1 |
| Concomitant diseases, n (%) | 20 (34) | 23 (40) | 0.7 |
| Previous therapy, n (%) | 7 (12) | 11(19) | 0.44 |
| Concomitant therapies, n (%) | 8 (14) | 10 (17) | 0.8 |